Related Experiment Video
Updated: Apr 4, 2026

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses
Katherine B Chiappinelli1, Pamela L Strissel2, Alexis Desrichard3
1Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21287, USA.
Abstract:
We show that DNA methyltransferase inhibitors (DNMTis) upregulate immune signaling in cancer through the viral defense pathway. In ovarian cancer (OC), DNMTis trigger cytosolic sensing of double-stranded RNA (dsRNA) causing a type I interferon response and apoptosis. Knocking down dsRNA sensors TLR3 and MAVS reduces this response 2-fold and blocking interferon beta or its receptor abrogates it. Upregulation of hypermethylated endogenous retrovirus (ERV) genes accompanies the response and ERV overexpression activates the response. Basal levels of ERV and viral defense gene expression significantly correlate in primary OC and the latter signature separates primary samples for multiple tumor types from The Cancer Genome Atlas into low versus high expression groups. In melanoma patients treated with an immune checkpoint therapy, high viral defense signature expression in tumors significantly associates with durable clinical response and DNMTi treatment sensitizes to anti-CTLA4 therapy in a pre-clinical melanoma model.
Insights
DNA methyltransferase inhibitors (DNMTis) activate cancer immune signaling via viral defense pathways. This triggers apoptosis in ovarian cancer and sensitizes melanoma to immunotherapy, highlighting a new therapeutic strategy.
Area of Science:
- Immunology
- Oncology
- Epigenetics
Background:
- DNA methyltransferase inhibitors (DNMTis) are investigated for cancer therapy.
- Immune signaling pathways are crucial in anti-tumor responses.
- Endogenous retroviruses (ERVs) and viral defense mechanisms are implicated in cancer.
Purpose of the Study:
- To elucidate the mechanism by which DNMTis modulate immune signaling in cancer.
- To investigate the role of viral defense pathways and ERVs in DNMTi-induced anti-cancer effects.
- To assess the potential of viral defense gene expression as a biomarker for immunotherapy response.
Main Methods:
- Treatment of ovarian cancer cells with DNMTis.
- Analysis of cytosolic sensing of double-stranded RNA (dsRNA) and type I interferon response.
- Knockdown of dsRNA sensors (TLR3, MAVS) and blockade of interferon beta or its receptor.
- Gene expression analysis of endogenous retroviruses (ERVs) and viral defense genes.
- Correlation analysis of gene expression in primary ovarian cancer and The Cancer Genome Atlas (TCGA) datasets.
- Analysis of viral defense signature in melanoma patient tumors treated with immune checkpoint therapy.
- Pre-clinical melanoma model studies with DNMTi and anti-CTLA4 therapy.
Main Results:
- DNMTis upregulate immune signaling through the viral defense pathway in cancer.
- In ovarian cancer, DNMTis induce dsRNA sensing, type I interferon response, and apoptosis.
- Knockdown of TLR3/MAVS or blocking interferon signaling significantly reduces DNMTi effects.
- Overexpression of hypermethylated ERV genes accompanies the immune response, and ERV overexpression activates it.
- Basal ERV and viral defense gene expression correlate in ovarian cancer and stratify TCGA samples.
- High viral defense signature in melanoma tumors predicts durable response to immune checkpoint therapy.
- DNMTi treatment sensitizes melanoma to anti-CTLA4 therapy in a pre-clinical model.
Conclusions:
- DNMTis harness the innate viral defense pathway to enhance anti-cancer immunity.
- The ERV-viral defense axis is a key mediator of DNMTi efficacy.
- Viral defense gene expression signatures may predict response to immunotherapy and guide treatment strategies.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Mechanisms of Retrovirus-induced Cancers
Mechanisms of Retrovirus-induced Cancers
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Viruses with RNA Genomes

